Related Experiment Video
Updated: Mar 23, 2026

11:13
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
2.5K
Young Barley Indicates Antitumor Effects in Experimental Breast Cancer In Vivo and In Vitro
Peter Kubatka1, Martin Kello2, Karol Kajo3
1a Department of Medical Biology , Jessenius Faculty of Medicine, Comenius University in Bratislava , Martin , Slovakia.
Nutrition and Cancer
|April 5, 2016
Summary
Young barley phytochemicals show a mild antitumor effect against mammary carcinogenesis in rats. Studies indicate barley reduces cancer cell survival and progression, suggesting potential in breast cancer prevention.
Area of Science:
- Phytochemistry
- Oncology
- Nutritional Science
Background:
- Dietary phytochemicals are investigated for cancer prevention.
- Young barley contains a mixture of bioactive compounds.
- Mammary carcinogenesis is a significant health concern.
Purpose of the Study:
- To evaluate the chemopreventive effect of young barley against N-methyl-N-nitrosourea-induced mammary carcinogenesis in female rats.
- To investigate the underlying mechanisms of action in vitro using MCF-7 breast cancer cells.
Main Methods:
- Female rats were administered N-methyl-N-nitrosourea and varying doses of young barley.
- Tumor tissues underwent histopathological and immunohistochemical analysis.
- In vitro studies utilized MCF-7 cells to assess cell survival, proliferation, and apoptosis.
Main Results:
- A mild antitumor effect was observed with 0.3% barley, but not with 3% barley.
- Barley increased caspase-3 expression and decreased Ki67 expression in rat tumor cells.
- In vitro, barley reduced MCF-7 cell survival, inhibited cell cycle progression, and induced apoptosis.
Conclusions:
- Young barley exhibits a chemopreventive effect against mammary carcinogenesis, likely due to its phytochemical mixture.
- Barley demonstrates potential as a dietary intervention for breast cancer prevention.
- Further research is warranted to elucidate the specific phytochemicals and mechanisms involved.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
6.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K

